Global cardiac monitoring and cardiac rhythm management devices market

Global Cardiac Monitoring and Cardiac Rhythm Management Devices Market Size, Share, Growth Analysis, By Product(cardiac monitoring and cardiac rhythm management devices and services), By End use(hospitals, ambulatory centers) - Industry Forecast 2024-2031

Report ID: SQMIG35A2212 | Region: Global | Published Date: February, 2024
Pages: 242 | Tables: 62 | Figures: 75

Global Cardiac Monitoring and Cardiac Rhythm Management Devices Market Competitive Landscape

There are a lot of large and medium-sized players in the global market for cardiac monitoring and cardiac rhythm management devices, which is fairly fragmented. Major players are employing a variety of strategies, concluding strategic agreements and contracts, entering into mergers and acquisitions, and developing and introducing more efficient devices.

Cardiac Monitoring and Cardiac Rhythm Management Devices Market Top Players Company Profiles

  • Medtronic

  • Boston Scientific

  • Abbott Laboratories

  • GE Healthcare

  • Philips Healthcare

  • St. Jude Medical

  • Nihon Kohden

  • Mortara Instrument

  • Schiller

  • Hill-Rom Holdings

  • Edwards Lifesciences

  • Welch Allyn

  • Spacelabs Healthcare

  • OSI Systems

  • Mindray Medical

  • Fukuda Denshi

  • BioTelemetry

  • Cardiac Science

  • Innomed Medical

Cardiac Monitoring and Cardiac Rhythm Management Devices Market

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Cardiac Monitoring and Cardiac Rhythm Management Devices Market size was valued at USD 17.82 billion in 2019 and is poised to grow from USD 18.8 billion in 2023 to USD 31.1 billion by 2031, growing at a CAGR of 5.5% in the forecast period (2024-2031).

There are a lot of large and medium-sized players in the global market for cardiac monitoring and cardiac rhythm management devices, which is fairly fragmented. Major players are employing a variety of strategies, concluding strategic agreements and contracts, entering into mergers and acquisitions, and developing and introducing more efficient devices. 'Biotronik SE & Co. KG', ' Medtronic ', ' Boston Scientific ', ' Abbott Laboratories ', ' GE Healthcare ', ' Philips Healthcare ', ' St. Jude Medical ', ' Nihon Kohden ', ' Mortara Instrument ', ' Schiller ', ' Hill-Rom Holdings ', ' Edwards Lifesciences ', ' Welch Allyn ', ' Spacelabs Healthcare ', ' OSI Systems ', ' Mindray Medical ', ' Fukuda Denshi ', ' BioTelemetry ', ' Cardiac Science ', ' Innomed Medical '

The key factors driving this market for cardiac monitoring and cardiac rhythm management devices include increasing prevalence of cardiovascular problems, rising expenses of treating cardiac diseases, rising use of ambulatory and home services, favorable government regulation, and technical improvements. The market for cardiac monitoring and cardiac rhythm management devices is being driven by the development of cutting-edge cardiac devices including MRI pacemakers, subcutaneous ICDs, and Automated External Defibrillators (AEDs). In the United States, cardiovascular diseases (CVDs) constitute a leading cause of death. According to the WHO, CVDs are thought to be the cause of one-fourth of all fatalities.

Today's cardiac rhythm management (CRM) devices are becoming more important for more than just monitoring and managing cardiac issues. They are also helping to restore, repair, and heal. Over the past few decades, the use of CRM devices has significantly increased as a result of rising life expectancy and ongoing technological advancements that have broadened their capabilities. Leading biotech companies have also made significant contributions to the field's R&D.

North America will dominate the global cardiac monitoring and cardiac rhythm management device market during the forecast period. The most common type of heart disease, coronary artery disease, affects 382,820 people in the United States, and approximately 805,000 Americans suffer from heart attacks annually.Another important factor driving market revenue growth is the presence of key players like Medtronic, Abbott, and General Electric Company, among others.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Related Reports

Global cardiac monitoring and cardiac rhythm management devices market

Report ID: UCMIG35A2091 | Region: Global | Published Date: February, 2024 | Pages: 165 | Tables: Figures:

Fractional Flow Reserve Market
Buy Now GET FREE SAMPLE
Global cardiac monitoring and cardiac rhythm management devices market

Report ID: UCMIG35A2077 | Region: Global | Published Date: February, 2024 | Pages: 165 | Tables: Figures:

Breast Imaging Market
Buy Now GET FREE SAMPLE
Global cardiac monitoring and cardiac rhythm management devices market

Report ID: UCMIG35A2464 | Region: Global | Published Date: February, 2024 | Pages: 165 | Tables: Figures:

Pregnancy Tracking And Postpartum Care Apps Market
Buy Now GET FREE SAMPLE
Global cardiac monitoring and cardiac rhythm management devices market

Report ID: UCMIG35A2943 | Region: Global | Published Date: February, 2024 | Pages: 165 | Tables: Figures:

Drug-coated Balloon Catheter Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global cardiac monitoring and cardiac rhythm management devices market

Product ID: SQMIG35A2212

$5,300
BUY NOW GET FREE SAMPLE